Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Unibios HoldingsATH:BIOSK +1.24%64 3-1 Month Momentum % is 2.14% as of Aug. 22, 2026. GuruFocus rates ATH:BIOSK with a GF Score™ of 64/100 and a GF Value™ of €1.48 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 3,072 Industrial Products companies, Unibios Holdings ranks better than 72.01% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-22), Unibios Holdings's 3-1 Month Momentum % is 2.14%.
The industry rank for Unibios Holdings's 3-1 Month Momentum % or its related term are showing as below:
ATH:BIOSK's 3-1 Month Momentum % is ranked better than 72.01% of 3072
companies
in the Industrial Products industry
Industry Median: -10.425
vs ATH:BIOSK: 2.14
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Unibios Holdings 3-1 Month Momentum % Related Terms
ATH:BIOSK vs VLTO, ZWS, CECO: 3-1 Month Momentum % Comparison
For the Pollution & Treatment Controls subindustry, Unibios Holdings's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unibios Holdings 3-1 Month Momentum % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Unibios Holdings's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Unibios Holdings's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Unibios Holdings (ATH:BIOSK) has a 3-1 Month Momentum % of 2.14% as of Aug. 22, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Unibios Holdings and its competitors. According to the industry distribution chart, Unibios Holdings ranks #860 out of 3072 companies in the Industrial Products industry, placing it in the top 28%.
Is Unibios Holdings' 3-1 Month Momentum % too high?
Unibios Holdings' current 3-1 Month Momentum % is 2.14%. Based on the distribution chart, Unibios Holdings ranks #860 out of 3072 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Unibios Holdings has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Unibios Holdings' 3-1 Month Momentum % compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Unibios Holdings ranks #860 out of 3072 companies for 3-1 Month Momentum %. This puts Unibios Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for an Industrial Products company?
A good 3-1 Month Momentum % depends on the Industrial Products industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Unibios Holdings and its competitors. Unibios Holdings's current 3-1 Month Momentum % is 2.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unibios Holdings stock overvalued right now?
Based on GuruFocus' analysis, Unibios Holdings (ATH:BIOSK) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.48, compared to a current price of €2.86 — trading 92.9% above its estimated fair value. The current 3-1 Month Momentum % is 2.14%. Unibios Holdings' overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Unibios Holdings (ATH:BIOSK), the current 3-1 Month Momentum % is 2.14% as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Unibios Holdings (ATH:BIOSK) Overvalued in 2026?
Based on GuruFocus' analysis, Unibios Holdings stock appears to be overvalued.
The current stock price of €2.86 is trading 92.9% above its estimated GF Value™ of €1.48.
GuruFocus considers Unibios Holdings to be Significantly Overvalued.
Key valuation signals for ATH:BIOSK:
3-1 Month Momentum %: 2.14%
GF Value™: €1.48 vs. price of €2.86 (92.9% above fair value)
No single metric tells the full story. See the ATH:BIOSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Unibios Holdings SA, through its subsidiaries, provides technologies for the responsible use of water and energy. Its activities include the treatment, filtration, water management, heating, and air conditioning, combined with energy saving.
64GF Score
Get the complete analysis for ATH:BIOSK
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ATH:BIOSK has been successfully added to your 
